Overlegen nr. 4 - 2016

OVERLEGEN 4-2016 46 popularity with the advancement of genomic, proteomic and diagnostic technologies in clinical practice. Apple recently announced that their ResearchKit apps can now import a user’s genetic data from the consumer testing service 23andMe. MyHeartCounts, a cardiovascular-disease app developed by Stanford University, will be the first to be able to easily incorporate users’ 23andMe data, if participants allow it [15]. Microsoft’s Connected Health Platform is a complex platform of tools, accelerators, solutions, prescriptive architecture, designs and deployment guidance for the digital health partners [16]. With the advancements in both hardware and sectors, the list of such emerging technologies in the field of diagnosis and health care treatment is long. At Oslo Cancer Cluster (OCC), we understand the importance to create and encourage the latest trending technologies and establish an upper edge in digital health for faster accurate disease diagnosis and personalised medicine. Supporting governmental initiatives and infrastructure will be critical towards establishing a transparent digital health society and shaping sustainable healthcare. • References: 1. Fiber, L., Medical Imaging Leaders Tap IBM and Watson to Tackle Cancer, Diabetes, Eye Health, Brain Disease and Heart Disease. http://www-03.ibm.com/press/us/en/pressrelease/49985.wss, 2016. 2. Intel Health and Life Sciences http://www.intel.co.uk/content/www/uk/en/healthcare-it/healthcare-overview.html. 3. Davis, J., Can Big Data Help Cure Cancer? InformationWeek, 2016. http://www.informationweek.com/big-data/big-data- analytics/can-big-data-help-cure-cancer-/d/d-id/1326295. 4. Medical Sieve. http://researcher.watson.ibm.com/researcher/view_group.php?id=4384. 5. Syeda-Mahmood, T., IBM Research. http://researcher.watson.ibm.com/researcher/view_group_pubs.php?grp=4384. 6. R idley, E.L., IBM's bid for Merge shows allure of imaging big data. AuntMinnie, 2015. http://www.auntminnie.com/ index.aspx?sec=ser&sub=def&pag=dis&ItemID=111685. 7. Investing in the National Cancer Moonshot. The White House: Office of the Press Secretary, 2016. https://www.whitehouse. gov/the-press-office/2016/02/01/fact-sheet-investing-national-cancer-moonshot. 8. Jakobsen, E., VISEPRESIDENTEN I USA SER TIL NORGE. https://www.kreftregisteret.no/Generelt/Nyheter/ visepresident-ser-til-norge/, 2016. 9. Joe Biden is looking to Norway. http://oslocancercluster.no/2016/09/23/joe-biden-is-looking-to-norway/, 2016. 10. Doi, K., Diagnostic imaging over the last 50 years: research and development in medical imaging science and technology. Phys Med Biol, 2006. 51(13): p. R5-27. 11. B ennett, C.C. and K. Hauser, Artificial intelligence framework for simulating clinical decision-making: a Markov decision process approach. Artif Intell Med, 2013. 57(1): p. 9-19. 12. Hern, A., 'Partnership on AI' formed by Google, Facebook, Amazon, IBM and Microsoft. theguardian, 2016. https://www.theguardian.com/technology/2016/sep/28/google-facebook-amazon-ibm-microsoft-partnership-on-ai-tech-firms. 13. IBMWatson. http://www.ibm.com/watson/index.html, 2016. 14. Kish, L.J. and E.J. Topol, Unpatients-why patients should own their medical data. Nat Biotechnol, 2015. 33(9): p. 921-4. 15. Check Hayden, E., Mobile-phone health apps deliver data bounty. Nature, 2016. 531(7595): p. 422-3. 16. Microsoft: Connected Health Platform. https://www.microsoft.com/health/en-ca/ict/Pages/connected-health-platform.aspx. OSLO CANCER CLUSTER GOES DIGITAL; OCC collaborations like, the project on Computing Applications for Individualized Cancer Control Programs: Cervical Cancer Screening together with Lawrence Livermore National Laboratory [34]; the IBM Watson Innovation Centre incubator collaboration focusing on cognitive technology in cancer diagnostics [4] and the IKTPLUSS Lighthouse Project on BIG data MEDical solution (BIGMED). The latter aims to address the analytic bottlenecks for the implementation of precision medicine [35]. OCC is part of the DoMore! project which addresses the significant problem in pathology i.e., heterogeneity in cancer; another IKTPLUSS Lighthouse Project supported by the Norwegian Research Council [36]. OCC recently started a H2020 project «PERMIDES» with a goal of combining the technologies from biopharma and IT industry for the benefit of patient community. This EU project with the sounding name «Personalised Medicine Innovation through Digital Enterprise Solutions: PERMIDES» will utilize digital tools and novel solutions from the IT sector to support the development of new cancer treatments [37]. BIOGRAPHICAL NOTES ON AUTHORS Ketil F. Widerberg, MBA, is General Manager of Oslo Cancer Cluster. He builds on a long experience in realizing new projects within oncology in the biopharmaceutical company Photocure ASA in collaboration with academic institutions and international commercial partners. Ketil knows big data integration/analytics through projects and transactions in the global software companies KSD Software and Descartes (DSG). Widerberg`s educational background spans from preclinical medical school to management studies. He also holds a MBA in economics/finance from the University of Cambridge. Ketil is the Chairman of Oslo Cancer Cluster Incubator. D.B.R.K. Gupta Udatha, PhD, is the Project Manager at Oslo Cancer Cluster. Gupta Udatha received doctoral degree from Chalmers University of Technology - Sweden. He has led the development of multi-national collaborations and coordinated research groups in academia & industry. Dr. Udatha has 10 years’ of R&D experience in the fields of bioinformatics, systems biology and big data analytics of biopharmaceutical data. He is also an entrepreneur and supporter of open-access publishing. He serves as the Publisher and Journal Manager of the Computational and Structural Biotechnology Journal. In addition, he is the Board Member of the Open Communications Press, which was formed by a team of academic researchers who believe in a more transparent and open system of academic publishing.

RkJQdWJsaXNoZXIy MTQ3Mzgy